aluates Reports

$ 0.0

Automative

Breast Cancer Therapeutics Drugs - Global Market Insights and Sales Trends 2024

Published Date: December 2023

Report Code: QYRE-Auto-24Q13573

Global Breast Cancer Therapeutics Drugs Market Research Report 2023

BUY CHAPTERS

Breast Cancer Therapeutics Drugs - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-24Q13573

Report

December 2023

Pages:123

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Breast Cancer Therapeutics Drugs - Market Size

The global Breast Cancer Therapeutics Drugs market size is expected to reach US$ 46070 million by 2029, growing at a CAGR of 8.2% from 2023 to 2029.

Breast Cancer Therapeutics Drugs - Market

Medicines include tamoxifen (Nolvadex) for women before and after menopause and aromatase inhibitors including anastrozole (Arimidex), exemestane (Aromasin), and letrozole (Femara) for postmenopausal women. Side effects can include hot flashes and vaginal dryness

The market is mainly driven by the significant applications of Breast Cancer Therapeutics Drugs in various end use industries. The expanding demands from the Phase I, Phase II and Phase III,, are propelling Breast Cancer Therapeutics Drugs market. Mitotic Inhibitors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Anti-Metabolites segment is estimated at % CAGR for the next seven-year period.

Breast cancer is the most common malignant tumor in the global female population, and data released by the International Agency for Research on Cancer (IARC) in 2020 show that about 2.26 million women will be diagnosed with breast cancer in 2020, surpassing the number of lung cancer diagnoses of 2.21 million for the first time, becoming the "number one cancer in the world." In China, the burden of breast cancer is no less heavy, and with the amplified effect of population ageing, the burden of disease in the female population is likely to increase further without sustained and effective intervention.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Breast Cancer Therapeutics Drugs, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Breast Cancer Therapeutics Drugs market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Breast Cancer Therapeutics Drugs market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Breast Cancer Therapeutics Drugs sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Breast Cancer Therapeutics Drugs covered in this report include Bayer HealthCare, Eli Lily, Pfizer, Novartis, Eisai, Halozyme Therapeutics, Roche, Puma Biotechnology and Janssen Biotech, etc.

The global Breast Cancer Therapeutics Drugs market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Bayer HealthCare

Eli Lily

Pfizer

Novartis

Eisai

Halozyme Therapeutics

Roche

Puma Biotechnology

Janssen Biotech

AbbVie

BioMarin

Array BioPharma

Merck

Syndax

MacroGenics

ImmunoGen

Santen Pharma

Celgene

Oncothyreon

AstraZeneca

Sprint Bioscience

Genentech

Galena Biopharma

Lycera

CTI BioPharma

Scope of Breast Cancer Therapeutics Drugs - Market Report

Report Metric	Details
Report Name	Breast Cancer Therapeutics Drugs - Market
Forecasted market size in 2029	US$ 46070 million
CAGR	8.2%
Forecasted years	2023 - 2029
Global Breast Cancer Therapeutics Drugs market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Breast Cancer Therapeutics Drugs market, Segment by Type:	Mitotic Inhibitors Anti-Metabolites Hormone Receptor Aromatase Inhibitors HER2 Inhibitors
Global Breast Cancer Therapeutics Drugs market, by Application	Phase I Phase II Phase III
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Breast Cancer Therapeutics Drugs companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What is the Breast Cancer Therapeutics Drugs - Market size in 2029?

Ans: The Breast Cancer Therapeutics Drugs - Market size in 2029 will be US$ 46070 million.

What are the Application segmentation covered in the Breast Cancer Therapeutics Drugs - Market report?

Ans: The Applications covered in the Breast Cancer Therapeutics Drugs - Market report are Phase I, Phase II, Phase III

What are the Type segmentation covered in the Breast Cancer Therapeutics Drugs - Market report?

Ans: The Types covered in the Breast Cancer Therapeutics Drugs - Market report are Mitotic Inhibitors, Anti-Metabolites, Hormone Receptor, Aromatase Inhibitors, HER2 Inhibitors

1 Market Overview of Breast Cancer Therapeutics Drugs

1.1 Breast Cancer Therapeutics Drugs Market Overview

1.1.1 Breast Cancer Therapeutics Drugs Product Scope

1.1.2 Breast Cancer Therapeutics Drugs Market Status and Outlook

1.2 Global Breast Cancer Therapeutics Drugs Market Size Overview by Region 2018 VS 2022 VS 2029

1.3 Global Breast Cancer Therapeutics Drugs Market Size by Region (2018-2029)

1.4 Global Breast Cancer Therapeutics Drugs Historic Market Size by Region (2018-2023)

1.5 Global Breast Cancer Therapeutics Drugs Market Size Forecast by Region (2024-2029)

1.6 Key Regions, Breast Cancer Therapeutics Drugs Market Size (2018-2029)

1.6.1 North America Breast Cancer Therapeutics Drugs Market Size (2018-2029)

1.6.2 Europe Breast Cancer Therapeutics Drugs Market Size (2018-2029)

1.6.3 Asia-Pacific Breast Cancer Therapeutics Drugs Market Size (2018-2029)

1.6.4 Latin America Breast Cancer Therapeutics Drugs Market Size (2018-2029)

1.6.5 Middle East & Africa Breast Cancer Therapeutics Drugs Market Size (2018-2029)

2 Breast Cancer Therapeutics Drugs Market by Type

2.1 Introduction

2.1.1 Mitotic Inhibitors

2.1.2 Anti-Metabolites

2.1.3 Hormone Receptor

2.1.4 Aromatase Inhibitors

2.1.5 HER2 Inhibitors

2.2 Global Breast Cancer Therapeutics Drugs Market Size by Type: 2018 VS 2022 VS 2029

2.2.1 Global Breast Cancer Therapeutics Drugs Historic Market Size by Type (2018-2023)

2.2.2 Global Breast Cancer Therapeutics Drugs Forecasted Market Size by Type (2024-2029)

2.3 Key Regions Market Size by Type

2.3.1 North America Breast Cancer Therapeutics Drugs Revenue Breakdown by Type (2018-2029)

2.3.2 Europe Breast Cancer Therapeutics Drugs Revenue Breakdown by Type (2018-2029)

2.3.3 Asia-Pacific Breast Cancer Therapeutics Drugs Revenue Breakdown by Type (2018-2029)

2.3.4 Latin America Breast Cancer Therapeutics Drugs Revenue Breakdown by Type (2018-2029)

2.3.5 Middle East and Africa Breast Cancer Therapeutics Drugs Revenue Breakdown by Type (2018-2029)

3 Breast Cancer Therapeutics Drugs Market Overview by Application

3.1 Introduction

3.1.1 Phase I

3.1.2 Phase II

3.1.3 Phase III

3.2 Global Breast Cancer Therapeutics Drugs Market Size by Application: 2018 VS 2022 VS 2029

3.2.1 Global Breast Cancer Therapeutics Drugs Historic Market Size by Application (2018-2023)

3.2.2 Global Breast Cancer Therapeutics Drugs Forecasted Market Size by Application (2024-2029)

3.3 Key Regions Market Size by Application

3.3.1 North America Breast Cancer Therapeutics Drugs Revenue Breakdown by Application (2018-2029)

3.3.2 Europe Breast Cancer Therapeutics Drugs Revenue Breakdown by Application (2018-2029)

3.3.3 Asia-Pacific Breast Cancer Therapeutics Drugs Revenue Breakdown by Application (2018-2029)

3.3.4 Latin America Breast Cancer Therapeutics Drugs Revenue Breakdown by Application (2018-2029)

3.3.5 Middle East and Africa Breast Cancer Therapeutics Drugs Revenue Breakdown by Application (2018-2029)

4 Breast Cancer Therapeutics Drugs Competition Analysis by Players

4.1 Global Breast Cancer Therapeutics Drugs Market Size by Players (2018-2023)

4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Breast Cancer Therapeutics Drugs as of 2022)

4.3 Date of Key Players Enter into Breast Cancer Therapeutics Drugs Market

4.4 Global Top Players Breast Cancer Therapeutics Drugs Headquarters and Area Served

4.5 Key Players Breast Cancer Therapeutics Drugs Product Solution and Service

4.6 Competitive Status

4.6.1 Breast Cancer Therapeutics Drugs Market Concentration Rate

4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles

5.1 Bayer HealthCare

5.1.1 Bayer HealthCare Profile

5.1.2 Bayer HealthCare Main Business

5.1.3 Bayer HealthCare Breast Cancer Therapeutics Drugs Products, Services and Solutions

5.1.4 Bayer HealthCare Breast Cancer Therapeutics Drugs Revenue (US$ Million) & (2018-2023)

5.1.5 Bayer HealthCare Recent Developments

5.2 Eli Lily

5.2.1 Eli Lily Profile

5.2.2 Eli Lily Main Business

5.2.3 Eli Lily Breast Cancer Therapeutics Drugs Products, Services and Solutions

5.2.4 Eli Lily Breast Cancer Therapeutics Drugs Revenue (US$ Million) & (2018-2023)

5.2.5 Eli Lily Recent Developments

5.3 Pfizer

5.3.1 Pfizer Profile

5.3.2 Pfizer Main Business

5.3.3 Pfizer Breast Cancer Therapeutics Drugs Products, Services and Solutions

5.3.4 Pfizer Breast Cancer Therapeutics Drugs Revenue (US$ Million) & (2018-2023)

5.3.5 Novartis Recent Developments

5.4 Novartis

5.4.1 Novartis Profile

5.4.2 Novartis Main Business

5.4.3 Novartis Breast Cancer Therapeutics Drugs Products, Services and Solutions

5.4.4 Novartis Breast Cancer Therapeutics Drugs Revenue (US$ Million) & (2018-2023)

5.4.5 Novartis Recent Developments

5.5 Eisai

5.5.1 Eisai Profile

5.5.2 Eisai Main Business

5.5.3 Eisai Breast Cancer Therapeutics Drugs Products, Services and Solutions

5.5.4 Eisai Breast Cancer Therapeutics Drugs Revenue (US$ Million) & (2018-2023)

5.5.5 Eisai Recent Developments

5.6 Halozyme Therapeutics

5.6.1 Halozyme Therapeutics Profile

5.6.2 Halozyme Therapeutics Main Business

5.6.3 Halozyme Therapeutics Breast Cancer Therapeutics Drugs Products, Services and Solutions

5.6.4 Halozyme Therapeutics Breast Cancer Therapeutics Drugs Revenue (US$ Million) & (2018-2023)

5.6.5 Halozyme Therapeutics Recent Developments

5.7 Roche

5.7.1 Roche Profile

5.7.2 Roche Main Business

5.7.3 Roche Breast Cancer Therapeutics Drugs Products, Services and Solutions

5.7.4 Roche Breast Cancer Therapeutics Drugs Revenue (US$ Million) & (2018-2023)

5.7.5 Roche Recent Developments

5.8 Puma Biotechnology

5.8.1 Puma Biotechnology Profile

5.8.2 Puma Biotechnology Main Business

5.8.3 Puma Biotechnology Breast Cancer Therapeutics Drugs Products, Services and Solutions

5.8.4 Puma Biotechnology Breast Cancer Therapeutics Drugs Revenue (US$ Million) & (2018-2023)

5.8.5 Puma Biotechnology Recent Developments

5.9 Janssen Biotech

5.9.1 Janssen Biotech Profile

5.9.2 Janssen Biotech Main Business

5.9.3 Janssen Biotech Breast Cancer Therapeutics Drugs Products, Services and Solutions

5.9.4 Janssen Biotech Breast Cancer Therapeutics Drugs Revenue (US$ Million) & (2018-2023)

5.9.5 Janssen Biotech Recent Developments

5.10 AbbVie

5.10.1 AbbVie Profile

5.10.2 AbbVie Main Business

5.10.3 AbbVie Breast Cancer Therapeutics Drugs Products, Services and Solutions

5.10.4 AbbVie Breast Cancer Therapeutics Drugs Revenue (US$ Million) & (2018-2023)

5.10.5 AbbVie Recent Developments

5.11 BioMarin

5.11.1 BioMarin Profile

5.11.2 BioMarin Main Business

5.11.3 BioMarin Breast Cancer Therapeutics Drugs Products, Services and Solutions

5.11.4 BioMarin Breast Cancer Therapeutics Drugs Revenue (US$ Million) & (2018-2023)

5.11.5 BioMarin Recent Developments

5.12 Array BioPharma

5.12.1 Array BioPharma Profile

5.12.2 Array BioPharma Main Business

5.12.3 Array BioPharma Breast Cancer Therapeutics Drugs Products, Services and Solutions

5.12.4 Array BioPharma Breast Cancer Therapeutics Drugs Revenue (US$ Million) & (2018-2023)

5.12.5 Array BioPharma Recent Developments

5.13 Merck

5.13.1 Merck Profile

5.13.2 Merck Main Business

5.13.3 Merck Breast Cancer Therapeutics Drugs Products, Services and Solutions

5.13.4 Merck Breast Cancer Therapeutics Drugs Revenue (US$ Million) & (2018-2023)

5.13.5 Merck Recent Developments

5.14 Syndax

5.14.1 Syndax Profile

5.14.2 Syndax Main Business

5.14.3 Syndax Breast Cancer Therapeutics Drugs Products, Services and Solutions

5.14.4 Syndax Breast Cancer Therapeutics Drugs Revenue (US$ Million) & (2018-2023)

5.14.5 Syndax Recent Developments

5.15 MacroGenics

5.15.1 MacroGenics Profile

5.15.2 MacroGenics Main Business

5.15.3 MacroGenics Breast Cancer Therapeutics Drugs Products, Services and Solutions

5.15.4 MacroGenics Breast Cancer Therapeutics Drugs Revenue (US$ Million) & (2018-2023)

5.15.5 MacroGenics Recent Developments

5.16 ImmunoGen

5.16.1 ImmunoGen Profile

5.16.2 ImmunoGen Main Business

5.16.3 ImmunoGen Breast Cancer Therapeutics Drugs Products, Services and Solutions

5.16.4 ImmunoGen Breast Cancer Therapeutics Drugs Revenue (US$ Million) & (2018-2023)

5.16.5 ImmunoGen Recent Developments

5.17 Santen Pharma

5.17.1 Santen Pharma Profile

5.17.2 Santen Pharma Main Business

5.17.3 Santen Pharma Breast Cancer Therapeutics Drugs Products, Services and Solutions

5.17.4 Santen Pharma Breast Cancer Therapeutics Drugs Revenue (US$ Million) & (2018-2023)

5.17.5 Santen Pharma Recent Developments

5.18 Celgene

5.18.1 Celgene Profile

5.18.2 Celgene Main Business

5.18.3 Celgene Breast Cancer Therapeutics Drugs Products, Services and Solutions

5.18.4 Celgene Breast Cancer Therapeutics Drugs Revenue (US$ Million) & (2018-2023)

5.18.5 Celgene Recent Developments

5.19 Oncothyreon

5.19.1 Oncothyreon Profile

5.19.2 Oncothyreon Main Business

5.19.3 Oncothyreon Breast Cancer Therapeutics Drugs Products, Services and Solutions

5.19.4 Oncothyreon Breast Cancer Therapeutics Drugs Revenue (US$ Million) & (2018-2023)

5.19.5 Oncothyreon Recent Developments

5.20 AstraZeneca

5.20.1 AstraZeneca Profile

5.20.2 AstraZeneca Main Business

5.20.3 AstraZeneca Breast Cancer Therapeutics Drugs Products, Services and Solutions

5.20.4 AstraZeneca Breast Cancer Therapeutics Drugs Revenue (US$ Million) & (2018-2023)

5.20.5 AstraZeneca Recent Developments

5.21 Sprint Bioscience

5.21.1 Sprint Bioscience Profile

5.21.2 Sprint Bioscience Main Business

5.21.3 Sprint Bioscience Breast Cancer Therapeutics Drugs Products, Services and Solutions

5.21.4 Sprint Bioscience Breast Cancer Therapeutics Drugs Revenue (US$ Million) & (2018-2023)

5.21.5 Sprint Bioscience Recent Developments

5.22 Genentech

5.22.1 Genentech Profile

5.22.2 Genentech Main Business

5.22.3 Genentech Breast Cancer Therapeutics Drugs Products, Services and Solutions

5.22.4 Genentech Breast Cancer Therapeutics Drugs Revenue (US$ Million) & (2018-2023)

5.22.5 Genentech Recent Developments

5.23 Galena Biopharma

5.23.1 Galena Biopharma Profile

5.23.2 Galena Biopharma Main Business

5.23.3 Galena Biopharma Breast Cancer Therapeutics Drugs Products, Services and Solutions

5.23.4 Galena Biopharma Breast Cancer Therapeutics Drugs Revenue (US$ Million) & (2018-2023)

5.23.5 Galena Biopharma Recent Developments

5.24 Lycera

5.24.1 Lycera Profile

5.24.2 Lycera Main Business

5.24.3 Lycera Breast Cancer Therapeutics Drugs Products, Services and Solutions

5.24.4 Lycera Breast Cancer Therapeutics Drugs Revenue (US$ Million) & (2018-2023)

5.24.5 Lycera Recent Developments

5.25 CTI BioPharma

5.25.1 CTI BioPharma Profile

5.25.2 CTI BioPharma Main Business

5.25.3 CTI BioPharma Breast Cancer Therapeutics Drugs Products, Services and Solutions

5.25.4 CTI BioPharma Breast Cancer Therapeutics Drugs Revenue (US$ Million) & (2018-2023)

5.25.5 CTI BioPharma Recent Developments

6 North America

6.1 North America Breast Cancer Therapeutics Drugs Market Size by Country (2018-2029)

6.2 U.S.

6.3 Canada

7 Europe

7.1 Europe Breast Cancer Therapeutics Drugs Market Size by Country (2018-2029)

7.2 Germany

7.3 France

7.4 U.K.

7.5 Italy

7.6 Russia

7.7 Nordic Countries

7.8 Rest of Europe

8 Asia-Pacific

8.1 Asia-Pacific Breast Cancer Therapeutics Drugs Market Size by Region (2018-2029)

8.2 China

8.3 Japan

8.4 South Korea

8.5 Southeast Asia

8.6 India

8.7 Australia

8.8 Rest of Asia-Pacific

9 Latin America

9.1 Latin America Breast Cancer Therapeutics Drugs Market Size by Country (2018-2029)

9.2 Mexico

9.3 Brazil

9.4 Rest of Latin America

10 Middle East & Africa

10.1 Middle East & Africa Breast Cancer Therapeutics Drugs Market Size by Country (2018-2029)

10.2 Turkey

10.3 Saudi Arabia

10.4 UAE

10.5 Rest of Middle East & Africa

11 Breast Cancer Therapeutics Drugs Market Dynamics

11.1 Breast Cancer Therapeutics Drugs Industry Trends

11.2 Breast Cancer Therapeutics Drugs Market Drivers

11.3 Breast Cancer Therapeutics Drugs Market Challenges

11.4 Breast Cancer Therapeutics Drugs Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

13.4 Author List

List of Tables

Table 1. Global Market Breast Cancer Therapeutics Drugs Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029

Table 2. Global Breast Cancer Therapeutics Drugs Market Size by Region (2018-2023) & (US$ Million)

Table 3. Global Breast Cancer Therapeutics Drugs Market Size Share by Region (2018-2023)

Table 4. Global Breast Cancer Therapeutics Drugs Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 5. Global Breast Cancer Therapeutics Drugs Forecasted Market Size Share by Region (2024-2029)

Table 6. Global Breast Cancer Therapeutics Drugs Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029

Table 7. Global Breast Cancer Therapeutics Drugs Market Size by Type (2018-2023) & (US$ Million)

Table 8. Global Breast Cancer Therapeutics Drugs Revenue Market Share by Type (2018-2023)

Table 9. Global Breast Cancer Therapeutics Drugs Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 10. Global Breast Cancer Therapeutics Drugs Revenue Market Share by Type (2024-2029)

Table 11. North America Breast Cancer Therapeutics Drugs Revenue by Type (2018-2023) & (US$ Million)

Table 12. North America Breast Cancer Therapeutics Drugs Revenue by Type (2024-2029) & (US$ Million)

Table 13. Europe Breast Cancer Therapeutics Drugs Revenue by Type (2018-2023) & (US$ Million)

Table 14. Europe Breast Cancer Therapeutics Drugs Revenue by Type (2024-2029) & (US$ Million)

Table 15. Asia-Pacific Breast Cancer Therapeutics Drugs Revenue by Type (2018-2023) & (US$ Million)

Table 16. Asia-Pacific Breast Cancer Therapeutics Drugs Revenue by Type (2024-2029) & (US$ Million)

Table 17. Latin America Breast Cancer Therapeutics Drugs Revenue by Type (2018-2023) & (US$ Million)

Table 18. Latin America Breast Cancer Therapeutics Drugs Revenue by Type (2024-2029) & (US$ Million)

Table 19. Middle East and Africa Breast Cancer Therapeutics Drugs Revenue by Type (2018-2023) & (US$ Million)

Table 20. Middle East and Africa Breast Cancer Therapeutics Drugs Revenue by Type (2024-2029) & (US$ Million)

Table 21. Global Breast Cancer Therapeutics Drugs Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029

Table 22. Global Breast Cancer Therapeutics Drugs Market Size by Application (2018-2023) & (US$ Million)

Table 23. Global Breast Cancer Therapeutics Drugs Revenue Market Share by Application (2018-2023)

Table 24. Global Breast Cancer Therapeutics Drugs Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 25. Global Breast Cancer Therapeutics Drugs Revenue Market Share by Application (2024-2029)

Table 26. North America Breast Cancer Therapeutics Drugs Revenue by Application (2018-2023) & (US$ Million)

Table 27. North America Breast Cancer Therapeutics Drugs Revenue by Application (2024-2029) & (US$ Million)

Table 28. Europe Breast Cancer Therapeutics Drugs Revenue by Application (2018-2023) & (US$ Million)

Table 29. Europe Breast Cancer Therapeutics Drugs Revenue by Application (2024-2029) & (US$ Million)

Table 30. Asia-Pacific Breast Cancer Therapeutics Drugs Revenue by Application (2018-2023) & (US$ Million)

Table 31. Asia-Pacific Breast Cancer Therapeutics Drugs Revenue by Application (2024-2029) & (US$ Million)

Table 32. Latin America Breast Cancer Therapeutics Drugs Revenue by Application (2018-2023) & (US$ Million)

Table 33. Latin America Breast Cancer Therapeutics Drugs Revenue by Application (2024-2029) & (US$ Million)

Table 34. Middle East and Africa Breast Cancer Therapeutics Drugs Revenue by Application (2018-2023) & (US$ Million)

Table 35. Middle East and Africa Breast Cancer Therapeutics Drugs Revenue by Application (2024-2029) & (US$ Million)

Table 36. Global Breast Cancer Therapeutics Drugs Revenue (US$ Million) by Players (2018-2023)

Table 37. Global Breast Cancer Therapeutics Drugs Revenue Market Share by Players (2018-2023)

Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Breast Cancer Therapeutics Drugs as of 2022)

Table 39. Date of Key Players Enter into Breast Cancer Therapeutics Drugs Market

Table 40. Global Breast Cancer Therapeutics Drugs Key Players Headquarters and Area Served

Table 41. Breast Cancer Therapeutics Drugs Product Solution and Service

Table 42. Global Breast Cancer Therapeutics Drugs Players Market Concentration Ratio (CR5 and HHI)

Table 43. Mergers & Acquisitions, Expansion Plans

Table 44. Bayer HealthCare Basic Information List

Table 45. Bayer HealthCare Description and Business Overview

Table 46. Bayer HealthCare Breast Cancer Therapeutics Drugs Products, Services and Solutions

Table 47. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Bayer HealthCare (2018-2023)

Table 48. Bayer HealthCare Recent Developments

Table 49. Eli Lily Basic Information List

Table 50. Eli Lily Description and Business Overview

Table 51. Eli Lily Breast Cancer Therapeutics Drugs Products, Services and Solutions

Table 52. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Eli Lily (2018-2023)

Table 53. Eli Lily Recent Developments

Table 54. Pfizer Basic Information List

Table 55. Pfizer Description and Business Overview

Table 56. Pfizer Breast Cancer Therapeutics Drugs Products, Services and Solutions

Table 57. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Pfizer (2018-2023)

Table 58. Pfizer Recent Developments

Table 59. Novartis Basic Information List

Table 60. Novartis Description and Business Overview

Table 61. Novartis Breast Cancer Therapeutics Drugs Products, Services and Solutions

Table 62. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Novartis (2018-2023)

Table 63. Novartis Recent Developments

Table 64. Eisai Basic Information List

Table 65. Eisai Description and Business Overview

Table 66. Eisai Breast Cancer Therapeutics Drugs Products, Services and Solutions

Table 67. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Eisai (2018-2023)

Table 68. Eisai Recent Developments

Table 69. Halozyme Therapeutics Basic Information List

Table 70. Halozyme Therapeutics Description and Business Overview

Table 71. Halozyme Therapeutics Breast Cancer Therapeutics Drugs Products, Services and Solutions

Table 72. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Halozyme Therapeutics (2018-2023)

Table 73. Halozyme Therapeutics Recent Developments

Table 74. Roche Basic Information List

Table 75. Roche Description and Business Overview

Table 76. Roche Breast Cancer Therapeutics Drugs Products, Services and Solutions

Table 77. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Roche (2018-2023)

Table 78. Roche Recent Developments

Table 79. Puma Biotechnology Basic Information List

Table 80. Puma Biotechnology Description and Business Overview

Table 81. Puma Biotechnology Breast Cancer Therapeutics Drugs Products, Services and Solutions

Table 82. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Puma Biotechnology (2018-2023)

Table 83. Puma Biotechnology Recent Developments

Table 84. Janssen Biotech Basic Information List

Table 85. Janssen Biotech Description and Business Overview

Table 86. Janssen Biotech Breast Cancer Therapeutics Drugs Products, Services and Solutions

Table 87. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Janssen Biotech (2018-2023)

Table 88. Janssen Biotech Recent Developments

Table 89. AbbVie Basic Information List

Table 90. AbbVie Description and Business Overview

Table 91. AbbVie Breast Cancer Therapeutics Drugs Products, Services and Solutions

Table 92. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of AbbVie (2018-2023)

Table 93. AbbVie Recent Developments

Table 94. BioMarin Basic Information List

Table 95. BioMarin Description and Business Overview

Table 96. BioMarin Breast Cancer Therapeutics Drugs Products, Services and Solutions

Table 97. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of BioMarin (2018-2023)

Table 98. BioMarin Recent Developments

Table 99. Array BioPharma Basic Information List

Table 100. Array BioPharma Description and Business Overview

Table 101. Array BioPharma Breast Cancer Therapeutics Drugs Products, Services and Solutions

Table 102. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Array BioPharma (2018-2023)

Table 103. Array BioPharma Recent Developments

Table 104. Merck Basic Information List

Table 105. Merck Description and Business Overview

Table 106. Merck Breast Cancer Therapeutics Drugs Products, Services and Solutions

Table 107. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Merck (2018-2023)

Table 108. Merck Recent Developments

Table 109. Syndax Basic Information List

Table 110. Syndax Description and Business Overview

Table 111. Syndax Breast Cancer Therapeutics Drugs Products, Services and Solutions

Table 112. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Syndax (2018-2023)

Table 113. Syndax Recent Developments

Table 114. MacroGenics Basic Information List

Table 115. MacroGenics Description and Business Overview

Table 116. MacroGenics Breast Cancer Therapeutics Drugs Products, Services and Solutions

Table 117. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of MacroGenics (2018-2023)

Table 118. MacroGenics Recent Developments

Table 119. ImmunoGen Basic Information List

Table 120. ImmunoGen Description and Business Overview

Table 121. ImmunoGen Breast Cancer Therapeutics Drugs Products, Services and Solutions

Table 122. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of ImmunoGen (2018-2023)

Table 123. ImmunoGen Recent Developments

Table 124. Santen Pharma Basic Information List

Table 125. Santen Pharma Description and Business Overview

Table 126. Santen Pharma Breast Cancer Therapeutics Drugs Products, Services and Solutions

Table 127. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Santen Pharma (2018-2023)

Table 128. Santen Pharma Recent Developments

Table 129. Celgene Basic Information List

Table 130. Celgene Description and Business Overview

Table 131. Celgene Breast Cancer Therapeutics Drugs Products, Services and Solutions

Table 132. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Celgene (2018-2023)

Table 133. Celgene Recent Developments

Table 134. Oncothyreon Basic Information List

Table 135. Oncothyreon Description and Business Overview

Table 136. Oncothyreon Breast Cancer Therapeutics Drugs Products, Services and Solutions

Table 137. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Oncothyreon (2018-2023)

Table 138. Oncothyreon Recent Developments

Table 139. AstraZeneca Basic Information List

Table 140. AstraZeneca Description and Business Overview

Table 141. AstraZeneca Breast Cancer Therapeutics Drugs Products, Services and Solutions

Table 142. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of AstraZeneca (2018-2023)

Table 143. AstraZeneca Recent Developments

Table 144. Sprint Bioscience Basic Information List

Table 145. Sprint Bioscience Description and Business Overview

Table 146. Sprint Bioscience Breast Cancer Therapeutics Drugs Products, Services and Solutions

Table 147. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Sprint Bioscience (2018-2023)

Table 148. Sprint Bioscience Recent Developments

Table 149. Genentech Basic Information List

Table 150. Genentech Description and Business Overview

Table 151. Genentech Breast Cancer Therapeutics Drugs Products, Services and Solutions

Table 152. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Genentech (2018-2023)

Table 153. Genentech Recent Developments

Table 154. Galena Biopharma Basic Information List

Table 155. Galena Biopharma Description and Business Overview

Table 156. Galena Biopharma Breast Cancer Therapeutics Drugs Products, Services and Solutions

Table 157. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Galena Biopharma (2018-2023)

Table 158. Galena Biopharma Recent Developments

Table 159. Lycera Basic Information List

Table 160. Lycera Description and Business Overview

Table 161. Lycera Breast Cancer Therapeutics Drugs Products, Services and Solutions

Table 162. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of Lycera (2018-2023)

Table 163. Lycera Recent Developments

Table 164. CTI BioPharma Basic Information List

Table 165. CTI BioPharma Description and Business Overview

Table 166. CTI BioPharma Breast Cancer Therapeutics Drugs Products, Services and Solutions

Table 167. Revenue (US$ Million) in Breast Cancer Therapeutics Drugs Business of CTI BioPharma (2018-2023)

Table 168. CTI BioPharma Recent Developments

Table 169. North America Breast Cancer Therapeutics Drugs Market Size by Country (2018-2023) & (US$ Million)

Table 170. North America Breast Cancer Therapeutics Drugs Market Size by Country (2024-2029) & (US$ Million)

Table 171. Europe Breast Cancer Therapeutics Drugs Market Size by Country (2018-2023) & (US$ Million)

Table 172. Europe Breast Cancer Therapeutics Drugs Market Size by Country (2024-2029) & (US$ Million)

Table 173. Asia-Pacific Breast Cancer Therapeutics Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 174. Asia-Pacific Breast Cancer Therapeutics Drugs Market Size by Region (2018-2023) & (US$ Million)

Table 175. Asia-Pacific Breast Cancer Therapeutics Drugs Market Size by Region (2024-2029) & (US$ Million)

Table 176. Asia-Pacific Breast Cancer Therapeutics Drugs Market Share by Region (2018-2023)

Table 177. Asia-Pacific Breast Cancer Therapeutics Drugs Market Share by Region (2024-2029)

Table 178. Latin America Breast Cancer Therapeutics Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 179. Latin America Breast Cancer Therapeutics Drugs Market Size by Country (2018-2023) & (US$ Million)

Table 180. Latin America Breast Cancer Therapeutics Drugs Market Size by Country (2024-2029) & (US$ Million)

Table 181. Middle East & Africa Breast Cancer Therapeutics Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 182. Middle East & Africa Breast Cancer Therapeutics Drugs Market Size by Country (2018-2023) & (US$ Million)

Table 183. Middle East & Africa Breast Cancer Therapeutics Drugs Market Size by Country (2024-2029) & (US$ Million)

Table 184. Breast Cancer Therapeutics Drugs Market Trends

Table 185. Breast Cancer Therapeutics Drugs Market Drivers

Table 186. Breast Cancer Therapeutics Drugs Market Challenges

Table 187. Breast Cancer Therapeutics Drugs Market Restraints

Table 188. Research Programs/Design for This Report

Table 189. Key Data Information from Secondary Sources

Table 190. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Breast Cancer Therapeutics Drugs Market Size Year-over-Year 2018-2029 & (US$ Million)

Figure 2. Global Breast Cancer Therapeutics Drugs Market Size (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Breast Cancer Therapeutics Drugs Market Share by Regions: 2022 VS 2029

Figure 4. Global Breast Cancer Therapeutics Drugs Forecasted Market Size Share by Region (2024-2029)

Figure 5. North America Breast Cancer Therapeutics Drugs Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 6. Europe Breast Cancer Therapeutics Drugs Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 7. Asia-Pacific Breast Cancer Therapeutics Drugs Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 8. Latin America Breast Cancer Therapeutics Drugs Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 9. Middle East & Africa Breast Cancer Therapeutics Drugs Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 10. Product Picture of Mitotic Inhibitors

Figure 11. Global Mitotic Inhibitors Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 12. Product Picture of Anti-Metabolites

Figure 13. Global Anti-Metabolites Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 14. Product Picture of Hormone Receptor

Figure 15. Global Hormone Receptor Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 16. Product Picture of Aromatase Inhibitors

Figure 17. Global Aromatase Inhibitors Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 18. Product Picture of HER2 Inhibitors

Figure 19. Global HER2 Inhibitors Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 20. Global Breast Cancer Therapeutics Drugs Market Size Share by Type: 2022 & 2029

Figure 21. North America Breast Cancer Therapeutics Drugs Revenue Market Share by Type (2018-2029)

Figure 22. Europe Breast Cancer Therapeutics Drugs Revenue Market Share by Type (2018-2029)

Figure 23. Asia-Pacific Breast Cancer Therapeutics Drugs Revenue Market Share by Type (2018-2029)

Figure 24. Latin America Breast Cancer Therapeutics Drugs Revenue Market Share by Type (2018-2029)

Figure 25. Middle East and Africa Breast Cancer Therapeutics Drugs Revenue Market Share by Type (2018-2029)

Figure 26. Phase I Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 27. Phase II Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 28. Phase III Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 29. Global Breast Cancer Therapeutics Drugs Market Size Share by Application: 2022 & 2029

Figure 30. North America Breast Cancer Therapeutics Drugs Revenue Market Share by Application (2018-2029)

Figure 31. Europe Breast Cancer Therapeutics Drugs Revenue Market Share by Application (2018-2029)

Figure 32. Asia-Pacific Breast Cancer Therapeutics Drugs Revenue Market Share by Application (2018-2029)

Figure 33. Latin America Breast Cancer Therapeutics Drugs Revenue Market Share by Application (2018-2029)

Figure 34. Middle East and Africa Breast Cancer Therapeutics Drugs Revenue Market Share by Application (2018-2029)

Figure 35. Breast Cancer Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

Figure 36. Global Top 5 and Top 10 Players Breast Cancer Therapeutics Drugs Market Share in 2022

Figure 37. North America Breast Cancer Therapeutics Drugs Market Share by Country (2018-2029)

Figure 38. U.S. Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)

Figure 39. Canada Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)

Figure 40. Germany Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)

Figure 41. France Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)

Figure 42. U.K. Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)

Figure 43. Italy Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)

Figure 44. Russia Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)

Figure 45. Nordic Countries Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)

Figure 46. Asia-Pacific Breast Cancer Therapeutics Drugs Market Share by Region (2018-2029)

Figure 47. China Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)

Figure 48. Japan Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)

Figure 49. South Korea Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)

Figure 50. Southeast Asia Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)

Figure 51. India Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)

Figure 52. Australia Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)

Figure 53. Latin America Breast Cancer Therapeutics Drugs Market Share by Country (2018-2029)

Figure 54. Mexico Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)

Figure 55. Brazil Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)

Figure 56. Middle East & Africa Breast Cancer Therapeutics Drugs Market Share by Country (2018-2029)

Figure 57. Turkey Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)

Figure 58. Saudi Arabia Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)

Figure 59. UAE Breast Cancer Therapeutics Drugs Market Size (2018-2029) & (US$ Million)

Figure 60. Bottom-up and Top-down Approaches for This Report

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Breast Cancer Therapeutics Drugs - Global Market Insights and Sales Trends 2024

Published Date: December 2023

Report Code: QYRE-Auto-24Q13573

Breast Cancer Therapeutics Drugs - Global Market Insights and Sales Trends 2024

FEATURED COMPANIES

Breast Cancer Therapeutics Drugs - Market Size

Breast Cancer Therapeutics Drugs - Market

Report Objectives

Key Features of The Study:

Scope of Breast Cancer Therapeutics Drugs - Market Report

Core Chapters

FAQ for this report

What is the Breast Cancer Therapeutics Drugs - Market size in 2029?

What are the Application segmentation covered in the Breast Cancer Therapeutics Drugs - Market report?

What are the Type segmentation covered in the Breast Cancer Therapeutics Drugs - Market report?

FEATURED COMPANIES